Literature DB >> 26500094

Upregulation of RICTOR gene transcription by the proinflammatory cytokines through NF-κB pathway contributes to the metastasis of renal cell carcinoma.

Bo Sun1, Liwei Chen1, Hui Fu1, Lin Guo1, Hua Guo2, Ning Zhang3,4.   

Abstract

Metastasis accounts for more than 50 % of deaths among renal cell carcinoma (RCC) patients, and therefore, it is important to study the biology of metastasis and identify metastasis-associated biomarkers for risk prognosis and stratification of patients for an individualized therapy of RCC. In cultured RCC cells, knockdown of Rictor by short hairpin RNA (shRNA) inhibited cell migration and invasion, probably due to impairments in activation of Akt. Pretreatment with tumor necrosis factor α (TNFα) or interleukin 6 (IL-6) enhanced the expression of Rictor and the migration of renal cancer cells. Mechanistic analysis showed that TNFα induced the activation of NF-κB in RCC cells. Luciferase reporter analysis revealed a NF-κB responding element (-301 to -51 bp) at the promoter region of Rictor. Chromatin immunoprecipitation (ChIP) analysis further confirmed that TNFα-induced binding of p65 with the promoter of Rictor. In a xenograft model, knockdown of Rictor-blocked RCC cells metastasis to the mouse lungs and livers. Taken together, our results suggest that the proinflammatory cytokine TNFα promotes the expression of Rictor through the NF-κB pathway.

Entities:  

Keywords:  Metastasis; NF-κB; Renal cell carcinoma; Rictor; TNFα

Mesh:

Substances:

Year:  2015        PMID: 26500094     DOI: 10.1007/s13277-015-4296-z

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  59 in total

Review 1.  Renal-cell carcinoma.

Authors:  R J Motzer; N H Bander; D M Nanus
Journal:  N Engl J Med       Date:  1996-09-19       Impact factor: 91.245

2.  RAFT1 phosphorylation of the translational regulators p70 S6 kinase and 4E-BP1.

Authors:  P E Burnett; R K Barrow; N A Cohen; S H Snyder; D M Sabatini
Journal:  Proc Natl Acad Sci U S A       Date:  1998-02-17       Impact factor: 11.205

3.  Preclinical characterization of OSI-027, a potent and selective inhibitor of mTORC1 and mTORC2: distinct from rapamycin.

Authors:  Shripad V Bhagwat; Prafulla C Gokhale; Andrew P Crew; Andy Cooke; Yan Yao; Christine Mantis; Jennifer Kahler; Jennifer Workman; Mark Bittner; Lorina Dudkin; David M Epstein; Neil W Gibson; Robert Wild; Lee D Arnold; Peter J Houghton; Jonathan A Pachter
Journal:  Mol Cancer Ther       Date:  2011-06-14       Impact factor: 6.261

4.  Long-range interactions between three transcriptional enhancers, active Vkappa gene promoters, and a 3' boundary sequence spanning 46 kilobases.

Authors:  Zhe Liu; William T Garrard
Journal:  Mol Cell Biol       Date:  2005-04       Impact factor: 4.272

5.  [Renal cell carcinoma management and therapies in 2010].

Authors:  B Albouy; M Gross Goupil; B Escudier; C Massard
Journal:  Bull Cancer       Date:  2010       Impact factor: 1.276

Review 6.  Targeting PI3K and mTORC2 in metastatic renal cell carcinoma: new strategies for overcoming resistance to VEGFR and mTORC1 inhibitors.

Authors:  Robert A Figlin; Isabelle Kaufmann; Jillian Brechbiel
Journal:  Int J Cancer       Date:  2013-02-12       Impact factor: 7.396

7.  Reduction of Akt2 inhibits migration and invasion of glioma cells.

Authors:  Baogang Zhang; Feng Gu; Chunhua She; Hua Guo; Wenliang Li; Ruifang Niu; Li Fu; Ning Zhang; Yongjie Ma
Journal:  Int J Cancer       Date:  2009-08-01       Impact factor: 7.396

8.  Safety, tolerability, pharmacokinetics and pharmacodynamics of AZD8055 in advanced solid tumours and lymphoma.

Authors:  A Naing; C Aghajanian; E Raymond; D Olmos; G Schwartz; E Oelmann; L Grinsted; W Burke; R Taylor; S Kaye; R Kurzrock; U Banerji
Journal:  Br J Cancer       Date:  2012-08-30       Impact factor: 7.640

Review 9.  Chronic inflammation and cytokines in the tumor microenvironment.

Authors:  Glauben Landskron; Marjorie De la Fuente; Peti Thuwajit; Chanitra Thuwajit; Marcela A Hermoso
Journal:  J Immunol Res       Date:  2014-05-13       Impact factor: 4.818

10.  Th17-type cytokines, IL-6 and TNF-α synergistically activate STAT3 and NF-kB to promote colorectal cancer cell growth.

Authors:  V De Simone; E Franzè; G Ronchetti; A Colantoni; M C Fantini; D Di Fusco; G S Sica; P Sileri; T T MacDonald; F Pallone; G Monteleone; C Stolfi
Journal:  Oncogene       Date:  2014-09-01       Impact factor: 9.867

View more
  7 in total

1.  Targeting mTORC2 component rictor inhibits cell proliferation and promotes apoptosis in gastric cancer.

Authors:  Yu-Hai Bian; Jia Xu; Wen-Yi Zhao; Zi-Zhen Zhang; Lin Tu; Hui Cao; Zhi-Gang Zhang
Journal:  Am J Transl Res       Date:  2017-09-15       Impact factor: 4.060

2.  Rictor regulates the vasculogenic mimicry of melanoma via the AKT-MMP-2/9 pathway.

Authors:  Xingmei Liang; Ran Sun; Xiulan Zhao; Yanhui Zhang; Qiang Gu; Xueyi Dong; Danfang Zhang; Junying Sun; Baocun Sun
Journal:  J Cell Mol Med       Date:  2017-07-12       Impact factor: 5.310

3.  Inhibition of mTORC2/RICTOR Impairs Melanoma Hepatic Metastasis.

Authors:  Katharina M Schmidt; Peter Dietrich; Christina Hackl; Jessica Guenzle; Peter Bronsert; Christine Wagner; Stefan Fichtner-Feigl; Hans J Schlitt; Edward K Geissler; Claus Hellerbrand; Sven A Lang
Journal:  Neoplasia       Date:  2018-11-04       Impact factor: 5.715

4.  Sunitinib-suppressed miR-452-5p facilitates renal cancer cell invasion and metastasis through modulating SMAD4/SMAD7 signals.

Authors:  Wei Zhai; Saiyang Li; Jin Zhang; Yonghui Chen; Junjie Ma; Wen Kong; Dongkui Gong; Junhua Zheng; Wei Xue; Yunfei Xu
Journal:  Mol Cancer       Date:  2018-11-12       Impact factor: 27.401

5.  KRASG12C Can Either Promote or Impair Cap-Dependent Translation in Two Different Lung Adenocarcinoma Cell Lines.

Authors:  George Kyriakopoulos; Vicky Katopodi; Ilias Skeparnias; Eleni G Kaliatsi; Katerina Grafanaki; Constantinos Stathopoulos
Journal:  Int J Mol Sci       Date:  2021-02-23       Impact factor: 5.923

6.  Rictor Activates Cav 1 Through the Akt Signaling Pathway to Inhibit the Apoptosis of Gastric Cancer Cells.

Authors:  Rui-Zhen Cao; Li Min; Si Liu; Ru-Yue Tian; Hai-Yan Jiang; Juan Liu; Lin-Lin Shao; Rui Cheng; Sheng-Tao Zhu; Shui-Long Guo; Peng Li
Journal:  Front Oncol       Date:  2021-09-01       Impact factor: 6.244

7.  Fbxw7 regulates renal cell carcinoma migration and invasion via suppression of the epithelial-mesenchymal transition.

Authors:  Hongchao He; Jun Dai; Zhaoping Xu; Wei He; Xiaojing Wang; Yu Zhu; Haofei Wang
Journal:  Oncol Lett       Date:  2018-01-08       Impact factor: 2.967

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.